Clene Inc.
CLNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822791
No open-market purchases or sales by Clene Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $19.6M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Clene Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 29 | 28 | −1 |
| Shares | 783.8K | 1.94M | +1.15M (+147.2%) |
| Value | $4.72M | $11.4M | +$6.65M (+140.9%) |
New holders (3)
Institutions that held Clene Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| SymBiosis Capital Partners, LLC | 770,495 | $4.52M | 4.13% |
| Boxer Capital Management, LLC | 199,737 | $1.17M | 0.26% |
| PEAK6 LLC | 50,012 | $293.6K | 0.01% |
Sold out (4)
Institutions that held Clene Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Renaissance Technologies LLC | 30,440 | $183.4K |
| Marshall Wace, LLP | 22,709 | $136.9K |
| Principal Securities, Inc. | 15 | $90 |
| Citigroup Inc | 1 | $6 |